MOLECULAR EXPRESS, INC — Department of Health and Human Services SBIR Phase I: 76

MOLECULAR EXPRESS, INC — SBIR Phase I award from Department of Health and Human Services.

Amount
$299,961
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
76
NAICS
Place of performance
CA
Period

Description

This proposal aim to develop a HIV antigen-conjugated VesiVax liposome, that can be co-formulated with various immunostimulatory adjuvant molecules (IAMs).These formulations will be evaluated in mice for the most immunogenic formulation(s).The selected formulations will then be evaluated for optima antigen and adjuvant doses.